Stearns Financial Services Group reduced its stake in shares of CVS Health Corp (NYSE:CVS) by 7.2% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,837 shares of the pharmacy operator’s stock after selling 762 shares during the period. Stearns Financial Services Group’s holdings in CVS Health were worth $800,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Fieldpoint Private Securities LLC boosted its holdings in CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,000 shares in the last quarter. Arcadia Investment Management Corp MI boosted its holdings in CVS Health by 119.6% in the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after purchasing an additional 726 shares in the last quarter. MPS Loria Financial Planners LLC bought a new stake in CVS Health in the second quarter worth $119,000. Gemmer Asset Management LLC boosted its holdings in CVS Health by 15.3% in the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after purchasing an additional 200 shares in the last quarter. Finally, Captrust Financial Advisors bought a new stake in CVS Health in the second quarter worth $155,000. Institutional investors and hedge funds own 81.63% of the company’s stock.

A number of brokerages recently issued reports on CVS. Raymond James Financial reiterated a “buy” rating on shares of CVS Health in a report on Monday, December 4th. Deutsche Bank reiterated a “hold” rating on shares of CVS Health in a report on Tuesday, December 5th. Royal Bank of Canada set a $95.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a report on Monday, December 4th. Robert W. Baird set a $77.00 target price on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, December 4th. Finally, Jefferies Group set a $76.00 target price on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, December 4th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have assigned a buy rating to the company. CVS Health presently has a consensus rating of “Buy” and an average target price of $86.35.

In related news, EVP Thomas M. Moriarty sold 20,547 shares of the company’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $81.17, for a total value of $1,667,799.99. Following the sale, the executive vice president now owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.61% of the company’s stock.

CVS Health Corp (NYSE:CVS) opened at $71.67 on Tuesday. The company has a market cap of $74,029.46, a PE ratio of 12.80, a PEG ratio of 1.37 and a beta of 0.89. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67. CVS Health Corp has a 52-week low of $66.45 and a 52-week high of $84.72.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.01. The business had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.64 earnings per share. sell-side analysts forecast that CVS Health Corp will post 5.9 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.watchlistnews.com/cvs-health-corp-cvs-shares-sold-by-stearns-financial-services-group/1772531.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.